Avita Medical | Despesas Operacionais



Operating Expenses Alterar Data
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Celltrion KRW 718.99B 24.68B 2025-06
Clinuvel Pharmaceuticals AUD 20.71M 2.35M 2024-06
Cochlear AUD 897.2M 19.8M 2024-12
CSL USD 5.72B 173M 2024-12
Cspc Pharmaceutical CNY 5.22B 248.9M 2025-03
Dianthus Therapeutics USD 35.12M 1.88M 2025-06
Divis Laboratories Ltd 17.93B 130M 2025-06
Kangmei Pharma CNY 1.25B 35.75M 2025-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 132.33M 179.02M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 103.54M 9.39M 2024-06
Medical Developments International AUD 19.8M 9.46M 2024-12
Nanosonics AUD 84.9M 42.29M 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 72.9M 18.86M 2025-06
Pacific Edge NZD 26.27M 12.77M 2024-09
Paradigm Biopharmaceuticals AUD 6.36M 8.6M 2024-12
Pharma Mar EUR 32.29M 9.66M 2025-06
Polynovo AUD 27.51M 19.08M 2024-06
PYC Therapeutics AUD 38.58M 20.29M 2024-12
Qiagen NV USD 397.57M 39.27M 2025-06
Ramsay Health Care AUD 8.35B 258.6M 2024-12
ResMed USD 891.42M 26.57M 2025-06
Sartorius EUR 722.5M 23.1M 2025-06
Sino Biopharmaceutical CNY 11.66B 352.34M 2024-12
Telix Pharmaceuticals AUD 191.9M 130.08M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.68B 272.39M 2025-06


Avita Medical Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.